https://www.statista.com/statistics/417687/analgesics-self-medication-market-sales-in-europe/. 2020. Statista, Inc. 55 Broad Street; 30th floor. New York, United States.
Carrasco-Garrido P, de Andres AL, Barrera VH, Jimenez-Trujillo I, Fernandez-de-Las-Penas C, Palacios-Cena D, et al. Predictors of self-medicated analgesic use in Spanish adults: a national cross-sectional study. BMC Pharmacol Toxicol. 2014;15:36.
Diener HC, Schneider R, Aicher B. Consumption of analgesics per capita: a survey in nine countries over 20 years. J Headache Pain. 2008;9:225–31.
The Swedish Parliament and government offices. Law 2009:730. [Lag om handel med vissa receptfria läkemedel, 2009]. https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/lag-2009730-om-handel-med-vissa-receptfria_sfs-2009-730.
Hedenrud T, Andersson Sundell K, Martinsson J, Hakonsen H. Attitudes towards the sale and use of over-the-counter drugs in Sweden in a reregulated pharmaceutical market: a population-based study. Int J Pharm Pract. 2019;27:17–24.
Carrasco-Garrido P, Jimenez-Garcia R, Barrera VH, Gil de Miguel A. Predictors of self-medication drug use among the Spanish adult population. Pharmacoepidemiol Medication Saf. 2008;17:193–9.
Hargreave M, Andersen TV, Nielsen A, Munk C, Liaw KL, Kjaer SK. Factors associated with regular and continuous use of painkillers – a population-based study of over 45,000 Danish women and men aged 18-45. Pharmacoepidemiol Medication Saf. 2010;19:65–74.
Backryd E. Gender differences in analgesics dispensed in Sweden between 2006 and 2015: an observational, nationwide, population-based study. Int J Women’s Health. 2018;10:55–64.
Schenck-Gustafsson K. Handbook of Gender Clinical Medicine. Basel: Karger; 2012.
Antonov K, Isacson D. Use of analgesics in Sweden – importance of socio-demographic factors, physical condition, health and health-related factors, and working conditions. Soc SciMed. 1982;1996(42):1473–81.
Google Scholar
Sarganas G, Buttery AK, Zhuang W, Wolf IK, Grams D, Rosario AS, et al. Prevalence, trends, patterns and associations of analgesic use in Germany. BMC Pharmacol Toxicol. 2015;16:28.
Witkiewitz K, Vowles KE. Alcohol and opioid use, co-use, and chronic pain in the context of the opioid epidemic: a critical review. Alcohol Clin Exp Res. 2018;42:478–88.
Zgierska A, Brown RT, Zuelsdorff M, Brown D, Zhang Z, Fleming MF. Sleep problems and daytime sleepiness in patients with chronic noncancer pain receiving long-term opioid therapy: a cross-sectional study. J Opioid management. 2007;3:317–27.
Appelberg K, Romanov K, Honkasalo ML, Koskenvuo M. The use of tranquilizers, hypnotics, and analgesics among 18,592 Finnish adults: associations with recent interpersonal conflict at work or with a spouse. J Clin Epidemiol. 1993;46:1315–22.
Koushede V, Holstein BE, Andersen A, Ekholm O, Hansen EH. Use of over-the-counter analgesics and perceived stress among 25-44 year olds. Pharmacoepidemiol Medication Saf. 2010;19:351–7.
Vowles KE, Bailey RW, McEntee ML, Pielech M, Edwards KA, Bolling LA, et al. Analgesic use for emotional modulation is associated with increased distress, depression, and risk of opioid and alcohol abuse: Baseline assessment and component analysis of reasons for measuring use. analgesics (RAUM). Clin J Pain. 2018;34:975–82.
Lissner L, Sjoberg A, Schutze M, Lapidus L, Hulthen L, Bjorkelund C. Diet, obesity, and obesogenic tendencies in two generations of Swedish women. Eur J Nutr. 2008;47:424–31.
Koushede V, Holstein BE, Andersen A, Hansen EH. Stress and headache medication: does sense of coherence alter the association? Eur J Public Health. 2011;21:656–61.
Bengtsson C, Blohme G, Hallberg L, Hallstrom T, Isaksson B, Korsan-Bengtsen K, et al. The Gothenburg Women’s Study 1968-1969 – a population study. General design, purpose and sampling results. Acta Med Scand. 1973;193:311–8.
Bengtsson C, Ahlqwist M, Andersson K, Bjorkelund C, Lissner L, Soderstrom M. The prospective study of the population of women in Gothenburg, Sweden, 1968–69 to 1992–93. A 24-year follow-up study with particular reference to participation, representativeness and mortality. Scand J Prim Health Care. 1997;15:214–9.
Bjorkelund C, Andersson-Hange D, Andersson K, Bengtsson C, Blomstrand A, Bondyr-Carlsson D, et al. Secular trends in cardiovascular risk factors with a 36-year perspective: 38- and 50-year-old observations in the population-based study of women in Gothenburg. Scand J Prim Health Care. 2008;26:140–6.
Rodstrom K, Weman L, Sandin L, Hange D, Bjorkelund C. Is it possible to survey the age of menopause? A comparative cross-sectional study of five cohorts between 1968 and 2017 of the Population Study of Women in Gothenburg, Sweden. Menopause. 2020;27:430–6.
WHO Collaborating Center for Drug Statistics Methodology, Guidelines for ATC Classification and DDD Assignment 2013. Oslo, 2012.
Hange D, Mehlig K, Lissner L, Guo X, Bengtsson C, Skoog I, et al. Perceived mental stress in women associated with psychosomatic symptoms, but not mortality: findings from the population study of women in Gothenburg, Sweden. Int J Gen Med. 2013;6:307–15.
Helgesson O, Cabrera C, Lapidus L, Bengtsson C, Lissner L. Self-reported stress levels predict later breast cancer in a cohort of Swedish women. Eur J Cancer Prev. 2003;12:377–81.
Bengtsson C, Hällström T, Tibblin G. Social factors, experience of stress, and personality traits in women with ischemic heart disease, compared to a population sample of women. Acta Med Scand Supp. 1973: 82–92.
Waller M, Lissner L, Hange D, Sund V, Blomstrand A, Bjorkelund C. Socioeconomic disparities in physical activity among Swedish women and trends over time: the demographic study of women in Gothenburg. Scand J Prim Health Care. 2018;36:363–71.
Hange D, Sigurdsson JA, Björkelund C, Sundh V, Bengtsson C. A 32-year longitudinal study of alcohol consumption among Swedish women: reduced risk of myocardial infarction but increased risk of cancer. Scand J Prim Health Care. 2015;33(3):153–62.
Wranker LS, Elmstahl S, Ekstrom H. Pain and alcohol: a comparison of two cohorts of 60-year-old women and men: results from the Good Aging in Skane study. Scand J Pain. 2018;18:611–20.
Jylha M. Ten-year change in medication use among older adults – a longitudinal study and cohort comparison. J Clin Epidemiol. 1994;47:69–79.
Eggen AE. Pattern of drug use in a general population – prevalence and predictive factors: the Tromso study. Int J Epidemiol. 1994;23:1262–72.
Stasio MJ, Curry K, Sutton-Skinner KM, Glassman DM. Use of over-the-counter medications and herbal or dietary supplements in college: dose frequency and relationship to self-reported distress. J Am Coll Health. 2008;56:535–47.
Pelfrene E, Vlerick P, Moreau M, Mak RP, Kornitzer M, De Backer G. Benzodiazepine use and perceived job stress in a cohort of working men and women in Belgium. Results of the BELSTRESS study. Soc SciMed. 2004;59:433–42.
Jerez-Roig J, Medeiros LF, Silva VA, Bezerra CL, Cavalcante LA, Piuvezam G, et al. Prevalence of self-medication and associated factors in an older population: a systematic review. Aging drugs. 2014;31:883–96.
Dale O, Borchgrevink PC, Fredheim OM, Mahic M, Romundstad P, Skurtveit S. Prevalence of non-prescription analgesic use in the Norwegian population HUNT3: impact of gender, age, exercise and prescription of opioids. BMC Public Health. 2015;15:461.
The National Board of Health and Welfare, Sweden. Medication statistics. [Statistik om läkemedel]. 2020. https://sdb.socialstyrelsen.se/if_lak/val.aspx.
Hedenrud T, Hakonsen H. Purchasing habits, paracetamol use, and sources of information in a reregulated Swedish pharmaceutical market: a population-based study. Health policy. 2017;121:35–41.
Medicines Committee, Region Västra Götaland, Sweden. Regional medical guidelines. [Regionala medicinska riktlinjer]. 2016-2017.
Axelsson MA, Spetz M, Mellen A, Wallerstedt SM. Use and attitudes towards the prescribing orientation booklet among primary care physicians. BMC Clin Pharmacol. 2008;8:8.
Hakonsen H, Sundell KA, Martinsson J, Hedenrud T. Consumer preferences for over-the-counter drug retailers in the reregulated Swedish pharmaceutical market. Health policy. 2016;120:327–33.
To continue. 2019. https://www.resume.se/marknadsforing/reklam/ipren-var-en-av-de-forsta-virala-filmerna-stort-misstag-att-lagga-ner/.
Sibbald B. Rofecoxib (Vioxx) voluntarily withdrawn from the market. CMAJ. 2004;171:1027–8.
Hakonsen H, Hedenrud T. A population-based study of risk perceptions of paracetamol use among Swedes – with a particular focus on young adults. Pharmacoepidemiol Medication Saf. 2017;26:992–7.
